Attached files
| file | filename |
|---|---|
| 10-Q/A - FORM 10-Q/A - OPIANT PHARMACEUTICALS, INC. | v425174_10qa.htm |
| EX-31.1 - EXHIBIT 31.1 - OPIANT PHARMACEUTICALS, INC. | v425174_ex31-1.htm |
| EX-10.2 - EXHIBIT 10.2 - OPIANT PHARMACEUTICALS, INC. | v425174_ex10-2.htm |
| EX-10.1 - EXHIBIT 10.1 - OPIANT PHARMACEUTICALS, INC. | v425174_ex10-1.htm |
EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER,
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES –OXLEY ACT OF 2002
I, Kevin Pollack, Chief Financial Officer of Lightlake Therapeutics Inc., certify that:
1. I have reviewed this Quarterly Report on Form 10-Q/A of Lightlake Therapeutics Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: November 19, 2015
| By: | /s/ Kevin Pollack | ||
| Kevin Pollack | |||
| Chief Financial Officer | |||
| (Principal Financial and Accounting Officer) | |||